Psallidas 2018 Table 2A clinical PROMISE for malignant pleural effusion: chemo 0/4, radiotherapy 0/2, haemoglobin g/dL 0-4, WBC 10^9/L 0/2/4/7/10, CRP mg/L 0/3/5/8/11, ECOG 0-1=0 or 2-4=7, cancer mesothelioma 0 / other 4 / lung 5. Groups A 0-20 <25%, B 21-27, C 28-35, D >35 >=75% 3-month mortality. Not TIMP1. Not a treatment order.
| Network | Scheme | Amount | Pay To |
|---|---|---|---|
| Base | exact | $0.005000 USDC | 0x836B...9Ee2 |